{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T10:42:35Z","timestamp":1697884955929},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":7930,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1984,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>General immunocompetence was examined in 125 patients with various stages of breast cancer. Tests include peripheral blood lymphocyte count, serum protein electrophoresis, quantitative immunoglobulins, CEA level, and delayed cutaneous hypersensitivity (DCH) reaction to six recall antigens (PPD, Monilia, mumps, Varidase, histoplasmin, and coccidioidin). About one third of the patients responded positively to each of the first four antigens, whereas 12% reacted to histoplasmin and 4% to coccidioidin. In this study, DCH to recall antigens had no prognostic value because the distributions of skin test reactivity were similar among patients with different stages of breast carcinoma. And among patients with similar stage of disease the relapse rates were similar for those who reacted and those who were anergic. But peripheral lymphocyte count had definite prognostic value because patients with advanced stage (group III\/IV) and those who were anergic had significantly lower lymphocyte counts. Among patients with relatively early stages of breast carcinoma (group I\/II), those who had higher lymphocyte count (\u2267 2,000\/mm<jats:sup>3<\/jats:sup>) had lower chance of having relapse up to 5 years after mastectomy.<\/jats:p>","DOI":"10.1002\/jso.2930270302","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T10:09:17Z","timestamp":1171966157000},"page":"135-140","source":"Crossref","is-referenced-by-count":5,"title":["Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma"],"prefix":"10.1002","volume":"27","author":[{"given":"Yeu\u2010Tsu N.(Margaret)","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197803000-00006"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.222.10.1301"},{"key":"e_1_2_1_4_2","unstructured":"Al\u2010SarrafM andCostanziJJ:Prognostic value of pre\u2010therapy total peripheral lymphocytes and white blood cells in patients with advanced malignant melanoma treated with chemotherapy and BCG\u2010A Southwest Oncology Group Study. Proc AACR ASCO 1978 p310."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1974.184"},{"key":"e_1_2_1_6_2","volume-title":"Cellular immunology, Cambridge","author":"Burnett M","year":"1969"},{"key":"e_1_2_1_7_2","first-page":"4612","article-title":"Prediction of survival in gynecological cancer based on immunological tests","volume":"40","author":"Check IJ","year":"1980","journal-title":"Cancer Res"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197604)37:4<1696::AID-CNCR2820370413>3.0.CO;2-9"},{"key":"e_1_2_1_9_2","first-page":"227","article-title":"Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy","volume":"4","author":"Davies CJ","year":"1978","journal-title":"Clin Oncol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930120309"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(78)90077-9"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO;2-V"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930180401"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800815)46:4 <908::AID-CNCR2820461310>3.0.CO;2-5"},{"key":"e_1_2_1_15_2","first-page":"311","article-title":"Peripheral blood lymphocyte counts and survival in breast cancer","volume":"23","author":"Fodor J","year":"1976","journal-title":"Neoplasma"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1976.225"},{"key":"e_1_2_1_17_2","first-page":"135","article-title":"Lymphocytes and breast cancer: Relationship of blood lymphocyte count to survival in breast cancer","volume":"72","author":"Holmes FF","year":"1971","journal-title":"J Kansas Med Soc"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197203000-00013"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-67166-1_12"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801015)46:8<1746::AID-CNCR2820460808>3.0.CO;2-U"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19821115)50:10<2016::AID-CNCR2820501007>3.0.CO;2-2"},{"key":"e_1_2_1_23_2","first-page":"435","article-title":"Peripheral lymphocyte count and subpopulations of T and B lymphocytes in benign and malignant disease","volume":"144","author":"Lee Y\u2010TN","year":"1977","journal-title":"Surg Gynec Obstet"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-468X(72)90019-0"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197708)40:2<667::AID-CNCR2820400212>3.0.CO;2-N"},{"key":"e_1_2_1_26_2","first-page":"69","article-title":"Peripheral lymphocyte counts and prognosis in malignant lymphomas","volume":"71","author":"Lee Y\u2010TN","year":"1974","journal-title":"Missouri Med"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197503)35:3<748::AID-CNCR2820350330>3.0.CO;2-X"},{"key":"e_1_2_1_28_2","first-page":"319","volume-title":"Prognostic Factors in Breast Cancer","author":"Mackay WD","year":"1968"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19821001)50:7<1280::AID-CNCR2820500710>3.0.CO;2-2"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01561511"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3138\/guthrie.40.1.048","article-title":"Cellular immune response to mastectomy and radiation","volume":"40","author":"Meyer KK","year":"1970","journal-title":"Guthrie Clin Bull"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197412)34:6<2014::AID-CNCR2820340620>3.0.CO;2-Q"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<164::AID-CNCR2820370123>3.0.CO;2-H"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197001)25:1<135::AID-CNCR2820250120>3.0.CO;2-9"},{"key":"e_1_2_1_35_2","first-page":"756","article-title":"Immunologic responses in cancer patients","volume":"121","author":"Solowey AC","year":"1965","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197609)38:3<1171::AID-CNCR2820380319>3.0.CO;2-8"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91401-5"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197609000-00003"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90395-6"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90085-4"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-197506000-00011"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1977.01370080089015"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.131.3.446"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930270302","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930270302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:44:06Z","timestamp":1697787846000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930270302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984,11]]}},"alternative-id":["10.1002\/jso.2930270302"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930270302","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,11]]}}}